Selective agonists at group II metabotropic glutamate receptors: synthesis, stereochemistry, and molecular pharmacology of (S)- and (R)-2-amino-4-(4-hydroxy[1,2,5]thiadiazol-3-yl)butyric acid

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Selective agonists at group II metabotropic glutamate receptors: synthesis, stereochemistry, and molecular pharmacology of (S)- and (R)-2-amino-4-(4-hydroxy[1,2,5]thiadiazol-3-yl)butyric acid. / Clausen, Rasmus P; Bräuner-Osborne, Hans; Greenwood, Jeremy R; Hermit, Mette B; Stensbøl, Tine B; Nielsen, Birgitte; Krogsgaard-Larsen, Povl.

In: Journal of Medicinal Chemistry, Vol. 45, No. 19, 12.09.2002, p. 4240-5.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Clausen, RP, Bräuner-Osborne, H, Greenwood, JR, Hermit, MB, Stensbøl, TB, Nielsen, B & Krogsgaard-Larsen, P 2002, 'Selective agonists at group II metabotropic glutamate receptors: synthesis, stereochemistry, and molecular pharmacology of (S)- and (R)-2-amino-4-(4-hydroxy[1,2,5]thiadiazol-3-yl)butyric acid', Journal of Medicinal Chemistry, vol. 45, no. 19, pp. 4240-5.

APA

Clausen, R. P., Bräuner-Osborne, H., Greenwood, J. R., Hermit, M. B., Stensbøl, T. B., Nielsen, B., & Krogsgaard-Larsen, P. (2002). Selective agonists at group II metabotropic glutamate receptors: synthesis, stereochemistry, and molecular pharmacology of (S)- and (R)-2-amino-4-(4-hydroxy[1,2,5]thiadiazol-3-yl)butyric acid. Journal of Medicinal Chemistry, 45(19), 4240-5.

Vancouver

Clausen RP, Bräuner-Osborne H, Greenwood JR, Hermit MB, Stensbøl TB, Nielsen B et al. Selective agonists at group II metabotropic glutamate receptors: synthesis, stereochemistry, and molecular pharmacology of (S)- and (R)-2-amino-4-(4-hydroxy[1,2,5]thiadiazol-3-yl)butyric acid. Journal of Medicinal Chemistry. 2002 Sep 12;45(19):4240-5.

Author

Clausen, Rasmus P ; Bräuner-Osborne, Hans ; Greenwood, Jeremy R ; Hermit, Mette B ; Stensbøl, Tine B ; Nielsen, Birgitte ; Krogsgaard-Larsen, Povl. / Selective agonists at group II metabotropic glutamate receptors: synthesis, stereochemistry, and molecular pharmacology of (S)- and (R)-2-amino-4-(4-hydroxy[1,2,5]thiadiazol-3-yl)butyric acid. In: Journal of Medicinal Chemistry. 2002 ; Vol. 45, No. 19. pp. 4240-5.

Bibtex

@article{f9854a1163034f70a87af6c23dbe2f84,
title = "Selective agonists at group II metabotropic glutamate receptors: synthesis, stereochemistry, and molecular pharmacology of (S)- and (R)-2-amino-4-(4-hydroxy[1,2,5]thiadiazol-3-yl)butyric acid",
abstract = "Homologation of analogues of the central excitatory neurotransmitter glutamic acid (Glu), in which the distal carboxy group has been bioisosterically replaced by acidic heterocyclic units, has previously provided subtype selective ligands for metabotropic Glu receptors (mGluRs). The (S)-form of the 1,2,5-thiadiazol-3-ol Glu analogue, 2-amino-3-(4-hydroxy[1,2,5]thiadiazol-3-yl)propionic acid (TDPA, 6), is an 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor agonist, which in addition stereospecifically activates group I mGluRs. We have now synthesized the (S)- and (R)-forms of 2-amino-4-(4-hydroxy[1,2,5]thiadiazol-3-yl)butyric acid (homo-TDPA, 7) and shown that whereas neither enantiomer interacts with AMPA receptors, (S)- and (R)-7 appear to be selective and equipotent agonists at group II mGluRs as represented by the mGluR2 subtype. The activities of (S)- and (R)-7 are rationalized by conformational analysis, comparison with the potent and specific group II mGluR agonist (-)-LY379268 [(-)-12], and docking to a homology model of mGluR2.",
keywords = "Amino Acids, Animals, Bicyclo Compounds, Heterocyclic, Binding Sites, Cerebral Cortex, Models, Molecular, Radioligand Assay, Rats, Receptors, Metabotropic Glutamate, Stereoisomerism, Structure-Activity Relationship, Thiadiazoles",
author = "Clausen, {Rasmus P} and Hans Br{\"a}uner-Osborne and Greenwood, {Jeremy R} and Hermit, {Mette B} and Stensb{\o}l, {Tine B} and Birgitte Nielsen and Povl Krogsgaard-Larsen",
year = "2002",
month = sep,
day = "12",
language = "English",
volume = "45",
pages = "4240--5",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "19",

}

RIS

TY - JOUR

T1 - Selective agonists at group II metabotropic glutamate receptors: synthesis, stereochemistry, and molecular pharmacology of (S)- and (R)-2-amino-4-(4-hydroxy[1,2,5]thiadiazol-3-yl)butyric acid

AU - Clausen, Rasmus P

AU - Bräuner-Osborne, Hans

AU - Greenwood, Jeremy R

AU - Hermit, Mette B

AU - Stensbøl, Tine B

AU - Nielsen, Birgitte

AU - Krogsgaard-Larsen, Povl

PY - 2002/9/12

Y1 - 2002/9/12

N2 - Homologation of analogues of the central excitatory neurotransmitter glutamic acid (Glu), in which the distal carboxy group has been bioisosterically replaced by acidic heterocyclic units, has previously provided subtype selective ligands for metabotropic Glu receptors (mGluRs). The (S)-form of the 1,2,5-thiadiazol-3-ol Glu analogue, 2-amino-3-(4-hydroxy[1,2,5]thiadiazol-3-yl)propionic acid (TDPA, 6), is an 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor agonist, which in addition stereospecifically activates group I mGluRs. We have now synthesized the (S)- and (R)-forms of 2-amino-4-(4-hydroxy[1,2,5]thiadiazol-3-yl)butyric acid (homo-TDPA, 7) and shown that whereas neither enantiomer interacts with AMPA receptors, (S)- and (R)-7 appear to be selective and equipotent agonists at group II mGluRs as represented by the mGluR2 subtype. The activities of (S)- and (R)-7 are rationalized by conformational analysis, comparison with the potent and specific group II mGluR agonist (-)-LY379268 [(-)-12], and docking to a homology model of mGluR2.

AB - Homologation of analogues of the central excitatory neurotransmitter glutamic acid (Glu), in which the distal carboxy group has been bioisosterically replaced by acidic heterocyclic units, has previously provided subtype selective ligands for metabotropic Glu receptors (mGluRs). The (S)-form of the 1,2,5-thiadiazol-3-ol Glu analogue, 2-amino-3-(4-hydroxy[1,2,5]thiadiazol-3-yl)propionic acid (TDPA, 6), is an 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor agonist, which in addition stereospecifically activates group I mGluRs. We have now synthesized the (S)- and (R)-forms of 2-amino-4-(4-hydroxy[1,2,5]thiadiazol-3-yl)butyric acid (homo-TDPA, 7) and shown that whereas neither enantiomer interacts with AMPA receptors, (S)- and (R)-7 appear to be selective and equipotent agonists at group II mGluRs as represented by the mGluR2 subtype. The activities of (S)- and (R)-7 are rationalized by conformational analysis, comparison with the potent and specific group II mGluR agonist (-)-LY379268 [(-)-12], and docking to a homology model of mGluR2.

KW - Amino Acids

KW - Animals

KW - Bicyclo Compounds, Heterocyclic

KW - Binding Sites

KW - Cerebral Cortex

KW - Models, Molecular

KW - Radioligand Assay

KW - Rats

KW - Receptors, Metabotropic Glutamate

KW - Stereoisomerism

KW - Structure-Activity Relationship

KW - Thiadiazoles

M3 - Journal article

C2 - 12213064

VL - 45

SP - 4240

EP - 4245

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 19

ER -

ID: 45613760